Impact of Cardiovascular Diseases on Mortality in Gastric Cancer Patients with Preexisting Chronic Disease

Kyu-Tae Han1, Dong Wook Kim2, Woorim Kim3

  • 1Division of Cancer Control & Policy, National Cancer Control Institute, National Cancer Center, Goyang, Korea.

Yonsei Medical Journal
|October 28, 2022
PubMed

Insights

Gastric cancer patients with common chronic diseases like hypertension or diabetes face higher mortality if diagnosed with cardiovascular disease (CVD) shortly before their cancer diagnosis. Managing CVD in these patients is crucial for improving survival outcomes.

Area of Science:

  • Oncology
  • Cardiology
  • Public Health

Background:

  • Chronic diseases and cardiovascular diseases (CVD) are independently associated with adverse cancer outcomes.
  • Gastric cancer patients with pre-existing hypertension, diabetes, or dyslipidemia represent a vulnerable population.

Purpose of the Study:

  • To determine if gastric cancer patients with hypertension, diabetes, or dyslipidemia have increased mortality when diagnosed with CVD within one year prior to their cancer diagnosis.
  • Investigate the impact of recent CVD incidence on 5-year mortality in this specific patient group.

Main Methods:

  • Utilized data from the National Health Insurance database (2002-2019).
  • Included gastric cancer patients with hypertension, diabetes, or dyslipidemia.
  • Employed survival analysis with Cox proportional hazards models to assess 5-year mortality.
  • Conducted subgroup analyses based on age, economic status, and initial treatment hospital type.

Main Results:

  • A total of 6458 patients were analyzed; 32.7% had a CVD diagnosis within the preceding year.
  • Patients diagnosed with CVD within one year before gastric cancer diagnosis exhibited a significantly higher risk of 5-year mortality (HR 1.259, 95% CI 1.138-1.394).
  • The increased mortality risk was more pronounced in patients of low economic status and those initially treated at general hospitals.

Conclusions:

  • Recent CVD diagnosis in gastric cancer patients with chronic conditions (hypertension, diabetes, dyslipidemia) is linked to elevated 5-year mortality.
  • Highlights the critical need for integrated management of chronic diseases and cardiovascular health in cancer patients.
  • Emphasizes proactive CVD risk assessment and management in gastric cancer patients with comorbidities.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.0K
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
673
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.1K